Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease-Reference-Cited by-同舟云学术

Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease

Published:2021-07 Issue: Volume:328 Page:1-10
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Zheng Ying-Ying,Wu Ting-Ting,Guo Qian-Qian,Chen You,Ma Xiang,Ma Yi-Tong,Zhang Jin-Ying,Xie Xiang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference48 articles.

1. OPTImal DUAL Antiplatelet Therapy Trial Investigators. Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial;Helft;Eur. Heart J.,2016

2. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N. Engl. J. Med.,2014

3. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus versus Cypher to Reduce Late Loss after Stenting (EXCELLENT) randomized, multicenter study;Gwon;Circulation,2012

4. RESET Investigators. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation);Kim;J. Am. Coll. Cardiol.,2012

5. Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT Substudy;Lee;EuroIntervention,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The higher the serum albumin, the better? Findings from the PRACTICE study;European Journal of Internal Medicine;2023-10

2. Cystatin C to Left Ventricular Ejection Fraction Ratio as a Novel Predictor of Adverse Outcomes in Patients with Coronary Artery Disease: A Prospective Cohort Study;Reviews in Cardiovascular Medicine;2023-09-18

3. Serum a‐1 antitrypsin as a novel biomarker in chronic heart failure;ESC Heart Failure;2023-07-07

4. The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort;Journal of Cardiovascular Translational Research;2023-06-22

5. Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients;Global Heart;2023